ArticleMolecular therapy. Oncology2026

Dissecting residual disease in spheroids reveals pan-cancer persistence signatures and a therapeutic window for oncolytic viruses.

Clara Fauveau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.